Page 1 of Clinical Trials for metformin, 1043 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
A Trial of Metformin for Colorectal Cancer Risk Reduction Among Patients With a History of Colorectal Adenomas and Elevated Body Mass Index
Last Updated: March 13, 2012
Condition(s): Precancerous Condition; Colorectal Adenomas; BMI Greater Than or Equal to 30, With Decimals Rounded to the Nearest Whole Integer
2
Completed
A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets
Last Updated: April 7, 2010
Condition(s): Type 2 Diabetes
3
Not yet recruiting
Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM
Last Updated: April 30, 2012
Condition(s): Type 2 Diabetes Mellitus
4
Completed
A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets
Last Updated: December 20, 2010
Condition(s): Healthy Volunteers
5
Completed
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)
Last Updated: April 19, 2011
Condition(s): Diabetes Mellitus
6
Completed
Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants
Last Updated: November 1, 2011
Condition(s): Type 2 Diabetes Mellitus
7
Withdrawn
BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States
Last Updated: June 1, 2011
Condition(s): Type 2 Diabetes
8
Completed
Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered
Last Updated: January 9, 2012
Condition(s): Type 2 Diabetes Mellitus
9
Active, not recruiting
Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients
Last Updated: July 15, 2009
Condition(s): Obesity
10
Active, not recruiting
Pharmacokinetics of Fixed Dose Combination (FDC) Tablets of Linagliptin /Metformin
Last Updated: May 2, 2012
Condition(s): Healthy
11
Recruiting
Clinical Trial to Evaluate Safety of Metformin Glycinate in Healthy Volunteers
Last Updated: March 20, 2012
Condition(s): Human Volunteers
12
Completed
A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets
Last Updated: April 7, 2010
Condition(s): Type 2 Diabetes
13
Not yet recruiting
Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets
Last Updated: January 23, 2012
Condition(s): Diabetes Mellitus Type 2
14
Completed
Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg
Last Updated: October 17, 2011
Condition(s): Type 2 Diabetes
15
Completed
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR
Last Updated: April 19, 2011
Condition(s): Diabetes Mellitus
16
Recruiting
Reducing Antipsychotic-Induced Weight Gain in Children With Metformin
Last Updated: October 29, 2010
Condition(s): Obesity; Weight Gain; Psychotropic Induced Weight Gain
17
Completed
Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet
Last Updated: May 2, 2012
Condition(s): Diabetes Mellitus, Type 2
18
Completed
Spironolactone Plus Metformin in Polycystic Ovary Syndrome
Last Updated: February 3, 2012
Condition(s): Polycystic Ovary Syndrome
19
Recruiting
Study of Metformin With Simvastatin for Men With Prostate Carcinoma
Last Updated: March 21, 2012
Condition(s): Prostate Carcinoma
20
Completed
Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus
Last Updated: September 13, 2011
Condition(s): Type 2 Diabetes Mellitus

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=metformin

Page 1 of Clinical Trials for metformin, 1043 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About